Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Berglund

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Lakartidningen|November 14, 2009
[SMiLE--a new grading model for physicians]David Berglund
Lakartidningen|January 11, 2007
[Grades superfluous in medical education)]David Berglund
Cytotherapy|November 26, 2016
Assessing the purity of regulatory T cells: A humble reminderErik Berglund, Felix Sellberg, David Berglund
Transfusion|February 17, 2015
Green plasmaDavid Berglund, Pernilla Lindvall, Norbert Lubenow
Upsala Journal of Medical Sciences|March 12, 2019
Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survivalJosefine Lundberg, David Berglund, Daniel Molin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 1, 2016
Inflammatory cytokines in serum samples of healthy blood donorsFelix Sellberg, Martin Ronaghi, Folke Knutson, et al.
Frontiers in Immunology|December 2, 2020
Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin <i>In Vitro</i>Christian Binder, Felix Sellberg, Filip Cvetkovski, et al.
Upsala Journal of Medical Sciences|March 21, 2014
Single-centre long-term follow-up of live kidney donors demonstrates preserved kidney function but the necessity of a structured lifelong follow-upBengt von Zur-Mühlen, David Berglund, Shinji Yamamoto, et al.
Frontiers in Oncology|January 28, 2021
Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral AgentFelix Sellberg, Robin Fröbom, Christian Binder, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2023
Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitroFilip Cvetkovski, Ronia Razavi, Felix Sellberg, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Lakartidningen|November 14, 2009
[SMiLE--a new grading model for physicians]David Berglund
Lakartidningen|January 11, 2007
[Grades superfluous in medical education)]David Berglund
Cytotherapy|November 26, 2016
Assessing the purity of regulatory T cells: A humble reminderErik Berglund, Felix Sellberg, David Berglund
Transfusion|February 17, 2015
Green plasmaDavid Berglund, Pernilla Lindvall, Norbert Lubenow
Upsala Journal of Medical Sciences|March 12, 2019
Intratumoral expression of FoxP3-positive regulatory T-cells in T-cell lymphoma: no correlation with survivalJosefine Lundberg, David Berglund, Daniel Molin, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 1, 2016
Inflammatory cytokines in serum samples of healthy blood donorsFelix Sellberg, Martin Ronaghi, Folke Knutson, et al.
Frontiers in Immunology|December 2, 2020
Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin <i>In Vitro</i>Christian Binder, Felix Sellberg, Filip Cvetkovski, et al.
Upsala Journal of Medical Sciences|March 21, 2014
Single-centre long-term follow-up of live kidney donors demonstrates preserved kidney function but the necessity of a structured lifelong follow-upBengt von Zur-Mühlen, David Berglund, Shinji Yamamoto, et al.
Frontiers in Oncology|January 28, 2021
Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral AgentFelix Sellberg, Robin Fröbom, Christian Binder, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 3, 2023
Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitroFilip Cvetkovski, Ronia Razavi, Felix Sellberg, et al.
Pageof 5